TerminatedPhase 2

Topical Voltaren in Otitis Externa

Israel20 participantsStarted 2008-09

Plain-language summary

Voltaren being a Non-steroidal anti-inflammatory drug (NSAID) drug may be used as a single drug therapy in otitis externa being both therapeutic and analgesic thus reducing consumption of oral analgesia.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adults having otitis externa as single diagnosis mild to moderate Exclusion Criteria: * Diabetes * Children * Pregnant women * Immune compromise * Starting other treatment * Moderate to severe otitis externa

What they're measuring

reducing oral analagestic use

Timeframe: 1 week

Trial details

NCT IDNCT00523120

SponsorSieff Medical Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2011-12

View on ClinicalTrials.gov More Otitis Externa trials